Detalles de la búsqueda
1.
Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
BMC Pulm Med;
23(1): 67, 2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805703
2.
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
Int J Cancer;
150(4): 626-635, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558665
3.
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
BMC Cancer;
21(1): 309, 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761908
4.
Different Impacts of Traffic-Related Air Pollution on Early-Onset and Late-Onset Asthma.
J Asthma Allergy;
17: 195-208, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38505396
5.
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Thorac Cancer;
15(7): 529-537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279515
6.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol;
16: 17588359231222604, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249338
7.
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.
Sci Rep;
13(1): 20323, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989860
8.
Efficacy of portable sleep monitoring device in diagnosing central sleep apnea in patients with congestive heart failure.
Front Neurol;
13: 1043413, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36619927
9.
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
Ther Adv Med Oncol;
14: 17588359221113278, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35898964
10.
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
Cancers (Basel);
14(2)2022 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053480
11.
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.
Sci Rep;
12(1): 4398, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292755
12.
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
Oncol Ther;
9(2): 489-503, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990928
13.
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
Ther Adv Med Oncol;
13: 17588359211035710, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377157
14.
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study.
Pharmaceuticals (Basel);
13(11)2020 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33113888
Resultados
1 -
14
de 14
1
Próxima >
>>